Table 5.
Characteristics (n = 41) | Univariate Logistic Regression | ||||
---|---|---|---|---|---|
Odds Ratio | 95% CI | p-Value | |||
Age, years | 1.179 | 1.000 | to | 1.390 | 0.049 |
Body mass index, kg/m2 | 0.969 | 0.827 | to | 1.135 | 0.697 |
Age of menarche, years | 1.113 | 0.604 | to | 2.052 | 0.731 |
Pregnancy | 0.533 | 0.043 | to | 6.655 | 0.625 |
Gestation | 1.817 | 0.873 | to | 3.783 | 0.110 |
Age of first pregnancy, years | 1.027 | 0.904 | to | 1.166 | 0.687 |
Breastfeeding | 0.828 | 0.075 | to | 9.074 | 0.877 |
Smoking | N.A. | ||||
Diabetes mellitus | N.A. | ||||
Lesion size, cm | 1.165 | 0.737 | to | 1.843 | 0.514 |
Abscess formation | 2.571 | 0.545 | to | 12.139 | 0.233 |
Multiple lesions | 1.591 | 0.279 | to | 9.066 | 0.601 |
Skin ulcer or fistula | 11.692 | 1.302 | to | 105.028 | 0.028 |
Symptom duration, weeks | 1.016 | 0.975 | to | 1.059 | 0.456 |
Bilateral lesions | 4.320 | 0.851 | to | 21.929 | 0.078 |
Extramammary manifestation | 2.857 | 0.601 | to | 13.586 | 0.187 |
Corynebacterium infection | 0.857 | 0.147 | to | 4.999 | 0.864 |
C-reactive protein, mg/dL | 1.874 | 1.139 | to | 3.084 | 0.013 |
Methotrexate use | 4.400 | 0.911 | to | 21.248 | 0.065 |
Surgery | 0.955 | 0.199 | to | 4.571 | >0.900 |
Time to resolution, weeks | 1.015 | 0.993 | to | 1.038 | 0.171 |
CI, confidence interval; N.A., not applicable.